Search
Displaying 511–520 of 756 for “retinitis clinical trial”
-
Brint Family Translational Research Award
The Brint Family Translational Research Program awards will accelerate the movement of preclinical research toward an Investigational New Drug filing and into clinical trials to provide a robust and diverse pipeline of potential therapies to fight inherited retinal degenerations (IRD) and dry age-related macular degeneration.
-
Inherited Retinal Disease Genetic Testing Webinar-Workshop for Eye Care Professionals
Foundation NewsHosted by the Foundation Fighting Blindness, Blueprint Genetics, and InformedDNA June 4, 2020, 12:00 p.m.–1:30 p.m. ET
-
Foundation and Vision Partners Seek Biomedical Research Support from Congress during COVID-19 Crisis
Foundation NewsDelays in Research Impacting Therapy Development
-
The VISIONS Team is working hard to secure the best science, information and lifestyle speakers for the visually impaired community. As more speakers are confirmed, we will list their name and information here, so check back often!
-
Foundation News
My Retina Tracker Program is the highest volume IRD genetic testing program in the U.S.
-
Offer support to patients with inherited eye diseases
In the PressWhile genetic testing can direct treatment and identify those at risk, it is important to have support available when patients test positive.
-
Foundation News
Known as Pro-EYS, the study will help researchers design clinical trials for potential therapies
-
Foundation News
The program will offer patients with inherited retinal disease no-cost genetic testing and genetic counseling in the United States. Look for updated information on how to participate to be posted in mid-October, with program registration starting shortly thereafter.
-
Career Development Program (CDA)
Objective/Goal: The goal of this Program is to facilitate advances in laboratory and clinical research, to elucidate the mechanisms for the etiology and pathogenesis of retinal degenerative diseases and to develop innovative strategies to prevent, treat and cure these diseases. This program supports up to five junior-level faculty for five (5) years. $75,000/year
-
Original Foundation Advocate Gertrude Weiss Celebrates 100th Birthday
Beacon StoriesGertrude Weiss was one of the early Foundation Fighting Blindness investors and advocates. Diagnosed with retinitis pigmentosa, Gertrude continues to live her life to the fullest. As a longtime friend, the Foundation honored Gertrude on her 100th birthday recently.
